Skip to Content
Merck
  • Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomics.

Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomics.

Drug metabolism letters (2009-08-26)
Jinchun Sun, Laura K Schnackenberg, Richard D Beger
ABSTRACT

A LC/MS-based metabolomic assay was utilized to investigate a drug's excretion kinetic profile in urine so that the drug toxicity information could be obtained. Groups of 10 male Sprague-Dawley rats per dose were orally gavaged with a single dose of 0.2% carboxymethylcellulose, 400 mg acetaminophen (APAP)/kg body weight or 1600 mg APAP/kg. UPLC/MS and NMR were used to evaluate the excretion kinetics of major drug metabolites. N-acetyl-L-cysteine acetaminophen (APAP-NAC) had statistically significant correlations with clinical chemistry data, endogenous metabolite concentrations and histopathology data. The potential toxicity of a drug can be assessed through the study of the drug's metabolite profiles.

MATERIALS
Product Number
Brand
Product Description

Supelco
Paracetamol β-D-glucuronide, analytical standard